FDA declines to approve reformulated Mallinckrodt opioid
December 12, 2018 at 06:54 AM EST
Mallinckrodt Plc said on Wednesday the U.S. Food and Drug Administration declined to approve an abuse-deterrent version of its opioid painkiller Roxicodone.
